Poly(ethylene glycol) modification of beta-glucuronidase-antibody conjugates for solid-tumor therapy by targeted activation of glucuronide prodrugs.

scientific article published in August 1997

Poly(ethylene glycol) modification of beta-glucuronidase-antibody conjugates for solid-tumor therapy by targeted activation of glucuronide prodrugs. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S002620050387
P698PubMed publication ID9298932
P5875ResearchGate publication ID13922304

P2093author name stringCheng TL
Chan LY
Wu PY
Roffler SR
Chern JW
Chen BM
P433issue6
P304page(s)305-315
P577publication date1997-08-01
P1433published inCancer Immunology, ImmunotherapyQ5031409
P1476titlePoly(ethylene glycol) modification of beta-glucuronidase-antibody conjugates for solid-tumor therapy by targeted activation of glucuronide prodrugs.
P478volume44